{"id":"W3096573094","doi":"10.1182/blood-2020-135872","title":"Robust Overall Survival and Sustained Efficacy Outcomes during Long Term Exposure to Momelotinib in JAK Inhibitor Naïve and Previously JAK Inhibitor Treated Intermediate/High Risk Myelofibrosis Patients","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sierra Wireless (Canada)","funders":"","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Internal medicine; Randomized controlled trial; Clinical endpoint; Dosing; Clinical trial; Phases of clinical research; Oncology; Anemia; Gastroenterology; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001410973,0.0002424539,0.0005235099,0.0002789898,0.0003879346,0.0007413554,0.0002824724,0.0004262558,0.001478142],"category_scores_gemma":[0.001527766,0.00009675121,0.0006251244,0.0002914317,0.0002293873,0.0005717226,0.0004591899,0.0007345183,0.0002712255],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005736683,"about_ca_system_score_gemma":0.0004947263,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007052846,"about_ca_topic_score_gemma":0.000850419,"domain_scores_codex":[0.9995103,0.0001224656,0.00004537267,0.000128914,0.00006590017,0.0001270828],"domain_scores_gemma":[0.9987754,0.0001757661,0.0004956796,0.00009098844,0.00007683435,0.0003853693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1023225,0.003995345,0.8131166,0.000140154,0.001116017,0.000639243,0.0004058087,0.001412717,0.01105821,0.00014216,0.001460404,0.06419081],"study_design_scores_gemma":[0.002104098,0.02948789,0.962859,0.00002399345,0.0005806223,0.0006676608,0.0001600181,0.001081729,0.001621122,0.0002029142,0.001178548,0.00003240082],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999008,0.0002660591,0.000051446,0.00003903018,0.000005524108,0.00002376425,0.0003097476,0.000004296463,0.0002922064],"genre_scores_gemma":[0.998672,0.00006912796,0.00004605648,0.00005803924,0.00001698389,0.00003170234,0.0009674724,0.000001373763,0.0001373158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001478142,"threshold_uncertainty_score":0.007462025,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01317963073518333,"score_gpt":0.2306525392479968,"score_spread":0.2174729085128135,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}